By analysing their accountability measures, goals, and measurable actions, a group of DEA members have evaluated the 10 biggest pharmaceutical firms in Australia's commitment to reaching net zero emissions.
According to their findings, Australia's top ten pharmaceutical businesses are all making progress toward net zero greenhouse gas emissions, but at varying rates. More qualitative study on industry-wide environmental sustainability policy and practice is required, and gaps in standardised reporting procedures should be filled.